Analystreport

Adamis Pharmaceuticals Corp (NASDAQ: ADMP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.

Adamis Pharmaceuticals Corporation  (ADMP) 
Last adamis pharmaceuticals corporation earnings: 11/12 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.adamispharmaceuticals.com/investor-overview